Annual report pursuant to Section 13 and 15(d)

EARNINGS (LOSS) PER SHARE (Details)

v3.22.4
EARNINGS (LOSS) PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
 5 Months Ended 7 Months Ended 12 Months Ended
May 17, 2021
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive common shares excluded from calculation of earnings per share (in shares) 0 0   0
Net income (loss) $ 250,994 $ (112,829) $ 494,701 $ (1,625,133)
Dividends on Preferred Stock 0 (4,573) (5,444) 0
Participating securities - Preferred Stock 0 0 (76,401) 0
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON STOCKHOLDERS 250,994 (117,402) 412,856 (1,625,133)
Re-allocation of participating securities 0 0 512 0
Net (loss) income attributable to common stockholders, diluted $ 250,994 $ (117,402) $ 413,368 $ (1,625,133)
Weighted average common shares outstanding - Basic (shares) 160,834,000 20,545,000 20,185,000 160,231,000
Weighted average common shares outstanding - Diluted (shares) 160,834,000 20,545,000 20,347,000 160,231,000
Basic (in dollars per share) $ 1.56 $ (5.71) $ 20.45 $ (10.14)
Diluted (in dollars per share) $ 1.56 $ (5.71) $ 20.32 $ (10.14)
Series A Convertible Preferred Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive common shares excluded from calculation of earnings per share (in shares)   4,100,000 3,700,000  
Restricted stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Anti-dilutive common shares excluded from calculation of earnings per share (in shares)   100,000 200,000